BIOLASE (BIOL) Competitors $0.0092 0.00 (-8.00%) As of 06/10/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock BIOL vs. NVIVQ, NAYA, DYNT, CUTR, SONX, STSS, IONM, AFIB, SDCCQ, and GMVDFShould you be buying BIOLASE stock or one of its competitors? The main competitors of BIOLASE include Invivo Therapeutics (NVIVQ), NAYA Biosciences (NAYA), Dynatronics (DYNT), Cutera (CUTR), Sonendo (SONX), Sharps Technology (STSS), Assure (IONM), Acutus Medical (AFIB), SmileDirectClub (SDCCQ), and G Medical Innovations (GMVDF). These companies are all part of the "medical equipment" industry. BIOLASE vs. Its Competitors Invivo Therapeutics NAYA Biosciences Dynatronics Cutera Sonendo Sharps Technology Assure Acutus Medical SmileDirectClub G Medical Innovations BIOLASE (NASDAQ:BIOL) and Invivo Therapeutics (NASDAQ:NVIVQ) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk. Which has better earnings and valuation, BIOL or NVIVQ? Invivo Therapeutics has lower revenue, but higher earnings than BIOLASE. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBIOLASE$48.83M0.01-$20.63M-$14.940.00Invivo TherapeuticsN/AN/A-$10.49MN/AN/A Does the MarketBeat Community believe in BIOL or NVIVQ? BIOLASE received 292 more outperform votes than Invivo Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformBIOLASEOutperform Votes29251.05% Underperform Votes28048.95% Invivo TherapeuticsN/AN/A Do institutionals & insiders hold more shares of BIOL or NVIVQ? 8.8% of BIOLASE shares are held by institutional investors. Comparatively, 12.3% of Invivo Therapeutics shares are held by institutional investors. 0.3% of BIOLASE shares are held by company insiders. Comparatively, 2.5% of Invivo Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is BIOL or NVIVQ more profitable? Invivo Therapeutics has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. Invivo Therapeutics' return on equity of 0.00% beat BIOLASE's return on equity.Company Net Margins Return on Equity Return on Assets BIOLASE-41.65% -1,782.73% -55.31% Invivo Therapeutics N/A N/A N/A Does the media refer more to BIOL or NVIVQ? In the previous week, BIOLASE's average media sentiment score of 0.00 equaled Invivo Therapeutics'average media sentiment score. Company Overall Sentiment BIOLASE Neutral Invivo Therapeutics Neutral Do analysts recommend BIOL or NVIVQ? BIOLASE currently has a consensus target price of $1.20, suggesting a potential upside of 12,943.48%. Given BIOLASE's stronger consensus rating and higher possible upside, analysts clearly believe BIOLASE is more favorable than Invivo Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BIOLASE 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Invivo Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, BIOL or NVIVQ? BIOLASE has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, Invivo Therapeutics has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. SummaryBIOLASE and Invivo Therapeutics tied by winning 6 of the 12 factors compared between the two stocks. Get BIOLASE News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIOL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOL vs. The Competition Export to ExcelMetricBIOLASEDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$307K$4.37B$5.57B$8.63BDividend YieldN/A2.13%5.28%4.18%P/E Ratio0.0050.5227.1320.06Price / Sales0.011.55412.28157.10Price / CashN/A6.5738.2534.64Price / Book-0.130.707.064.70Net Income-$20.63M-$153.72M$3.23B$247.88M7 Day PerformanceN/A2.14%2.86%2.63%1 Month PerformanceN/A-1.01%9.05%6.36%1 Year PerformanceN/A-16.01%31.39%14.05% BIOLASE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOLBIOLASE1.0195 of 5 stars$0.01-8.0%$1.20+12,943.5%-94.1%$307K$48.83M0.00160Gap DownNVIVQInvivo TherapeuticsN/A$0.37flatN/AN/A$1.15MN/A0.006High Trading VolumeNAYANAYA BiosciencesN/A$1.69-0.6%$24.00+1,320.1%N/A$1.13M$6.23M0.0010Gap DownDYNTDynatronicsN/A$0.08-0.1%N/A-78.5%$860K$33.60M-0.10200CUTRCutera1.3986 of 5 stars$0.04-63.9%$3.00+7,592.3%-97.9%$787K$155.21M-0.01460Gap DownHigh Trading VolumeSONXSonendo1.1432 of 5 stars$1.31-1.5%N/A+1,098.3%$562K$44.40M-0.02250Positive NewsShort Interest ↓Gap DownSTSSSharps Technology0.7978 of 5 stars$3.57-4.8%N/AN/A$193KN/A-0.443News CoverageIONMAssureN/A$0.05flatN/AN/A$150K$149K0.00130AFIBAcutus MedicalN/A$0.00-80.0%N/A-94.4%$60K$7.16M0.00340SDCCQSmileDirectClubN/AN/AN/AN/A$40K$470.74M0.002,700GMVDFG Medical InnovationsN/A$0.00flatN/AN/A$26K$4.42M0.0072 Related Companies and Tools Related Companies Invivo Therapeutics Alternatives NAYA Biosciences Alternatives Dynatronics Alternatives Cutera Alternatives Sonendo Alternatives Sharps Technology Alternatives Assure Alternatives Acutus Medical Alternatives SmileDirectClub Alternatives G Medical Innovations Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIOL) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
